{
    "organizations": [],
    "uuid": "0d62e322be978dae03d61e8c8227a92c578e026d",
    "author": "",
    "url": "https://www.reuters.com/article/brief-joseph-payne-reports-137-pct-stake/brief-joseph-payne-reports-13-7-pct-stake-in-arcturus-therapeutics-idUSFWN1Q31BG",
    "ord_in_thread": 0,
    "title": "BRIEF-Joseph Payne Reports 13.7 Pct Stake In Arcturus Therapeutics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Arcturus Therapeutics Ltd:\n* JOSEPH PAYNE SAYS EMAILED LETTER DATED FEBRUARY 12, REQUESTED BOARD OF ARCTURUS THERAPEUTICS CONVENE EXTRAORDINARY GENERAL MEETING AS SOON AS POSSIBLE\n* JOSEPH PAYNE REPORTS 13.7 PERCENT STAKE IN ARCTURUS THERAPEUTICS LTD AS OF FEBRUARY 12 - SEC FILING Source text : bit.ly/2srwU3Y Further company coverage:\n ",
    "published": "2018-02-13T18:48:00.000+02:00",
    "crawled": "2018-02-13T19:13:41.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "arcturus",
        "therapeutic",
        "ltd",
        "joseph",
        "payne",
        "say",
        "emailed",
        "letter",
        "dated",
        "february",
        "requested",
        "board",
        "arcturus",
        "therapeutic",
        "convene",
        "extraordinary",
        "general",
        "meeting",
        "soon",
        "possible",
        "joseph",
        "payne",
        "report",
        "percent",
        "stake",
        "arcturus",
        "therapeutic",
        "ltd",
        "february",
        "sec",
        "filing",
        "source",
        "text",
        "company",
        "coverage"
    ]
}